Genomic epidemiology of novel coronavirus (HCoV-19)
nextstrain.org
nextstrain.org
Edit: On a separate note, this tool is one of the best "web meets science" websites I've ever seen. Really nice work for those involved in its creation.
So the outbreak in Bavaria that was thought be contained somehow made its way to Italy? Or do these kind of interpretations not make any sense?
Early on the official guidance was that asymptomatic spread while possible is not playing a major role in global transmissions. Now we’re seeing the results of that position.
If you have the snuffles, are you supposed to react like it's COVID, or react like it's just one of the million other colds and such going around every winter until things get bad enough that your symptoms concern you?
If you react like it's COVID, then what - go to a hospital or otherwise burden the health system? All they can tell you is to quarantine yourself, unless/until it gets bad enough that it's worth testing you.
Another one is risk factor, like any ties with people who are infected or people who came from high risk areas.
If you just have the sniffles you probably shouldn't panic and go to the ER, but you should stay the hell away from big conventions and not go to work, at least within reason.
I work for a company that has unmetered sick leave (that you can take without people judging you), great VPN/work from home policy, and will actively shun people who come to work sick (that is, no one is even remotely close to being pressured to come for butt in seat time).
And people still come to work sniffling and coughing. I keep having to kick them back home day after day. Like, wtf, seriously.
Actually, as I'm typing this Im hearing someone coughing and sneezing a few rows from me, and yet again Ill have to talk to them and maybe even their manager, because here we're super privileged and there's exactly zero reason to come in sick.
I agree not everyone has that privilege, but if those who DO actually exercised it, it would at least have SOME impact on the spread.
For example in the USA, by only testing the highest risk categories, the positive rate is still only ~3%. Increases in the population screened will eventually lead to decreasing the positive rate. In that sense, broadening the criteria by which we do testing will lead to dilution of utility of resources. That's not to say that the choices we made were optimal, but rather to say that scaling our testing to the point where we are catching a significant portion of asymptomatic carriers may not have been the best choice.
Remember that both test consumables and testing capability are not unlimited.
You can model this out at home with different asymptomatic carrier rates and different transmission rates and find the optimal resource allocation for each case.
If so, will this virus just domesticate itself (or rather domesticated by humans filtering out those more deadly versions)? By domesticate I mean that it lives with us just like the common cold without causing a 10% dip in the stock market.
As to the question, yes, that can well happen.
Note that we could also argue that the common cold virus has domesticated us. We're its cattle.
in the short term, if a virus can replicate itself and pass on to another host , that will in turn transmit the virus,,, that means a success.
if debilitating symptoms occur after transmission occurs then those symptoms dont influence selection, this is what happens with asymptomatic incubation and infectious states.
this type of virus uses RNA to carry its code, and a property of RNA is that it is much more error prone than DNA so accidental variations in the code occur quite frequently. A lot of these variants fizzle out but some of them will chance across an advantageous change in the code.
so we see a virus that passes through populations and shifts its codeing by being error prone. this can result in dynamic swings between dominance of strains over time, and lead to innovations such as high communicability, or asymptomatic transmission.
This can apply to bacteria even more than viruses, see https://aeon.co/essays/when-bacteria-kill-us-it-s-more-accid...
EDIT: I should say, though, that you shouldn't expect that to happen quickly. The selective pressure for COVID-19 to become less lethal is far less than it was for, say, MERS.
https://www.businessinsider.com/iran-supreme-leader-khamenei...
These are the early stages of what looks to be a pandemic of a disease at least an order of magnitude, possibly several orders of magnitude [2], more lethal than seasonal flu, which is no picnic already. Isn't that enough to be worrying about, all on its own?
[2] CDC headline numbers for the 2019-2020 flu season, vs. the commonly given 2% lethality guesstimate.
The New England Journal of Medicine says it may likely be considerably less than 1%:
https://www.nejm.org/doi/full/10.1056/NEJMe2002387
People should remember the context of a respiratory disease in China. 2/3rds of men smoke, and air pollution is common. Things also spread faster there as it’s densely populated with lower hygiene standards than developed countries (for example: spitting is still common in some areas).
And, it does appear to be less lethal outside of China. That may be because healthcare systems are not yet overwhelmed, or it may be because of the smoking and pollution exposure in the different demographics. It is probably even both of those things.
They are guessing this shift could be due to a combination of reduced transmission load and refining treatment protocols.
So the question is why is it ominous that no one in Iran has isolated and uploaded a sequence?
Not ominous as in any way indicative of a conspiracy or otherwise.
Most of the initial testing was sent to Australia and I'm not sure what capability NZ medical labs have yet and I doubt they are sequencing much. There is a chance that the Iranian was sequenced, with media referred to a "deeper" testing protocol after initial tests where negative.
https://www.ncbi.nlm.nih.gov/labs/virus/vssi/#/virus?SeqType...